HR Execs on the Move

KOMET USA

www.komet-usa.com

 
KOMET USA is a Rock Hill, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

RoundGlass

RoundGlass is committed to enabling individuals to live their Journey of holistic Wellbeing and Meaningful Living™. The RoundGlass community of associates, portfolio companies, fellows, partners and ambassadors advocate and develop solutions across the RoundGlass holistic Wellbeing Pillars. The RoundGlass Wholistic Wellbeing Pillars: 1. Live – Wellbeing of self: From the right health care decision to celebrating life 2. Learn – Wellbeing of the future: Living with purpose and mastering key qualities 3. Give – Wellbeing of society: Empowering community wellbeing so that all members live with dignity 4. Sustain – Wellbeing of the planet: Meaningful programs that improve the environment

Weiler Engineering

Weiler Engineering is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

CSI Medical Education

CSI Medical Education is a Madison, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hunterdon Healthcare

The Hunterdon Healthcare System is a non-profit health care organization in Flemington, NJ committed to providing a full range of quality services that respond to the needs of the community. Hunterdon Medical Center is a 178-bed non-profit community hospital, providing a full range of preventive, diagnostic, and therapeutic inpatient and outpatient hospital and community health services.

AVEO Oncology

AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to discovering and developing targeted therapies designed to provide substantial impact in patients` lives with clear unmet medical needs. AVEO`s proprietary Human Response PlatformTM provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics.